Colonial Trust Advisors’s Novartis NVS Stock Holding History

Colonial Trust Advisors’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$218K	Sell	1,390 -46	-3%	-$6.9K	0.02%	202
2026 Q1	$219K	Hold	1,436	–	–	0.02%	193
2025 Q4	$198K	Sell	1,436 -437	-23%	-$57.2K	0.01%	200
2025 Q3	$240K	Buy	1,873 +872	+87%	+$106K	0.02%	188
2025 Q2	$121K	Sell	1,001 -1,275	-56%	-$144K	0.01%	244
2025 Q1	$254K	Buy	2,276 +1,776	+355%	+$189K	0.02%	184
2024 Q4	$48.7K	Hold	500	–	–	﹤0.01%	312
2024 Q3	$57.5K	Hold	500	–	–	0.01%	318
2024 Q2	$53.2K	Sell	500 -2	-0.4%	-$201	0.01%	316
2024 Q1	$48.6K	Buy	502 +2	+0.4%	+$205	﹤0.01%	331
2023 Q4	$50.5K	Sell	500 -300	-38%	-$29K	0.01%	319
2023 Q3	$81.5K	Hold	800	–	–	0.01%	272
2023 Q2	$80.7K	Hold	800	–	–	0.01%	279
2023 Q1	$73.6K	Hold	800	–	–	0.01%	288
2022 Q4	$72.6K	Hold	800	–	–	0.01%	286
2022 Q3	$61K	Buy	+800	New	+$66.3K	0.01%	227

Other funds holding NVS

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Colonial Trust Advisors's NVS Position: Q2 2026 in Review

Colonial Trust Advisors reduced its Novartis (NVS) stake by 3.2% in Q2 2026, selling an estimated $6.9K and leaving 1,390 shares worth $218K. The position accounts for 0.02% of the portfolio, ranked #202.

Colonial Trust Advisors first reported a position in NVS in Q3 2022 and has held it in 16 quarters since. The position peaked at $254K in Q1 2025. 1,620 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

Colonial Trust Advisors held 1,390 shares of Novartis worth $218K as of Q2 2026.
Colonial Trust Advisors sold 46 Novartis shares in Q2 2026, an estimated $6.9K.
Novartis made up 0.02% of Colonial Trust Advisors's portfolio in Q2 2026, its #202 holding.
Colonial Trust Advisors first reported a position in Novartis in Q3 2022 and has held it in 16 quarters since.
Colonial Trust Advisors's Novartis position peaked at $254K in Q1 2025.
1,620 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on Colonial Trust Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.